a company that engages in the development of therapies for metabolic and endocrine disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.
Ticker / NAME | Correlation To VKTX | 1D Price Change % | ||
---|---|---|---|---|
VKTX | 100% | -9.14% | ||
JANX - VKTX | 63% Loosely correlated | -1.61% | ||
DNLI - VKTX | 46% Loosely correlated | -0.87% | ||
LGND - VKTX | 45% Loosely correlated | +1.11% | ||
BEAM - VKTX | 41% Loosely correlated | -1.57% | ||
AKRO - VKTX | 40% Loosely correlated | -4.35% | ||
More |
Ticker / NAME | Correlation To VKTX | 1D Price Change % |
---|---|---|
VKTX | 100% | -9.14% |
VKTX (2 stocks) | 93% Closely correlated | -2.15% |
metabolic (5 stocks) | 54% Loosely correlated | +0.81% |
therapy (23 stocks) | 53% Loosely correlated | -1.93% |
challenging disorders (8 stocks) | 47% Loosely correlated | -1.64% |
drugs (254 stocks) | 38% Loosely correlated | -0.52% |
More |